Biologically Active Small Molecules, LKT Labs, Not dangerous goods, 1202757-89-8
1 - 1 of 1
Sort
View
Show
-
AVL-292
LKT LabsAVL-292 is a Bruton’s tyrosine kinase (BTK) inhibitor that exhibits anticancer chemotherapeutic activities. AVL-292 is in clinical development as a potential treatment for B-cell-related disorders such as chronic lymphocytic leukemia (CLL).
Site Search by